Literature DB >> 27588897

Timing the discussion of antiobesity medications during obesity treatment.

Candida J Rebello1, Patrick M O'Neil2, Deborah B Horn3, Frank L Greenway4.   

Abstract

Entities:  

Year:  2016        PMID： 27588897      PMCID： PMC5039074          DOI： 10.1002/oby.21614

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN： 1930-7381            Impact factor:   5.002


× No keyword cloud information.
  9 in total

1.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.

Authors:  Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

2.  Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity.

Authors:  Faidon Magkos; Gemma Fraterrigo; Jun Yoshino; Courtney Luecking; Kyleigh Kirbach; Shannon C Kelly; Lisa de Las Fuentes; Songbing He; Adewole L Okunade; Bruce W Patterson; Samuel Klein
Journal:  Cell Metab       Date:  2016-02-22       Impact factor: 27.287

3.  The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy.

Authors:  K Fujioka; R Plodkowski; P M O'Neil; K Gilder; B Walsh; F L Greenway
Journal:  Int J Obes (Lond)       Date:  2016-06-22       Impact factor: 5.095

4.  Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes.

Authors:  Steven R Smith; Patrick M O'Neil; Arne Astrup; Nicholas Finer; Matilde Sanchez-Kam; Kyle Fraher; Randi Fain; William R Shanahan
Journal:  Obesity (Silver Spring)       Date:  2014-07-18       Impact factor: 5.002

5.  Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010.

Authors:  Ying Xia; Christina M L Kelton; Jeff J Guo; Boyang Bian; Pamela C Heaton
Journal:  Obesity (Silver Spring)       Date:  2015-08       Impact factor: 5.002

6.  Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study.

Authors:  T A Wadden; P Hollander; S Klein; K Niswender; V Woo; P M Hale; L Aronne
Journal:  Int J Obes (Lond)       Date:  2013-07-01       Impact factor: 5.095

Review 7.  Barriers to obesity treatment.

Authors:  Marina Mauro; Valerie Taylor; Sean Wharton; Arya M Sharma
Journal:  Eur J Intern Med       Date:  2007-11-19       Impact factor: 4.487

8.  Predictors of early attrition and successful weight loss in patients attending an obesity management program.

Authors:  Dishay Jiandani; Sean Wharton; Michael A Rotondi; Chris I Ardern; Jennifer L Kuk
Journal:  BMC Obes       Date:  2016-03-09

9.  Evaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention.

Authors:  Jessica L Unick; Patricia E Hogan; Rebecca H Neiberg; Lawrence J Cheskin; Gareth R Dutton; Gina Evans-Hudnall; Robert Jeffery; Abbas E Kitabchi; Julie A Nelson; F Xavier Pi-Sunyer; Delia Smith West; Rena R Wing
Journal:  Obesity (Silver Spring)       Date:  2014-04-28       Impact factor: 5.002
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.